{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T17:12:28Z","timestamp":1795108348350,"version":"4.10.3"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["CA233100"],"award-info":[{"award-number":["CA233100"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA227388"],"award-info":[{"award-number":["R01CA227388"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-21-PCRP-DSA"],"award-info":[{"award-number":["W81XWH-21-PCRP-DSA"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","award":["PCF-Movember Challenge Award"],"award-info":[{"award-number":["PCF-Movember Challenge Award"]}],"id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-57377-6","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T03:57:57Z","timestamp":1740801477000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dissecting tumor cell programs through group biology estimation in clinical single-cell transcriptomics"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2388-3913","authenticated-orcid":false,"given":"Shreya","family":"Johri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Breanna M.","family":"Titchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4028-3661","authenticated-orcid":false,"given":"Jingxin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jett P.","family":"Crowdis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3766-5335","authenticated-orcid":false,"given":"Natalie I.","family":"Vokes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenghua","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6428-428X","authenticated-orcid":false,"given":"Lawrence","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihye","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0346-5033","authenticated-orcid":false,"given":"David","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng Xiao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0201-4444","authenticated-orcid":false,"given":"Eliezer M.","family":"Van Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,1]]},"reference":[{"key":"57377_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-015-0844-5","volume":"16","author":"G Finak","year":"2015","unstructured":"Finak, G. et al. MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data. Genome Biol. 16, 1\u201313 (2015).","journal-title":"Genome Biol."},{"key":"57377_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-017-02554-5","volume":"9","author":"D Risso","year":"2018","unstructured":"Risso, D., Perraudeau, F., Gribkova, S., Dudoit, S. & Vert, J.-P. A general and flexible method for signal extraction from single-cell RNA-seq data. Nat. Commun. 9, 1\u201317 (2018).","journal-title":"Nat. Commun."},{"key":"57377_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-021-02146-6","volume":"4","author":"L He","year":"2021","unstructured":"He, L. et al. NEBULA is a fast negative binomial mixed model for differential or co-expression analysis of large-scale multi-subject single-cell data. Commun. Biol. 4, 1\u201317 (2021).","journal-title":"Commun. Biol."},{"key":"57377_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-022-02605-1","volume":"23","author":"M Zhang","year":"2022","unstructured":"Zhang, M. et al. IDEAS: individual level differential expression analysis for single-cell RNA-seq data. Genome Biol. 23, 1\u201317 (2022).","journal-title":"Genome Biol."},{"key":"57377_CR5","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/s41587-021-00896-6","volume":"39","author":"A Cortal","year":"2021","unstructured":"Cortal, A., Martignetti, L., Six, E. & Rausell, A. Gene signature extraction and cell identity recognition at the single-cell level with Cell-ID. Nat. Biotechnol. 39, 1095\u20131102 (2021).","journal-title":"Nat. Biotechnol."},{"key":"57377_CR6","doi-asserted-by":"publisher","first-page":"101121","DOI":"10.1016\/j.xpro.2022.101121","volume":"3","author":"A Marquez-Galera","year":"2022","unstructured":"Marquez-Galera, A., de la Prida, L. M. & Lopez-Atalaya, J. P. A protocol to extract cell-type-specific signatures from differentially expressed genes in bulk-tissue RNA-seq. STAR Protoc. 3, 101121 (2022).","journal-title":"STAR Protoc."},{"key":"57377_CR7","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083\u20131086 (2017).","journal-title":"Nat. Methods"},{"key":"57377_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-12235-0","volume":"10","author":"D DeTomaso","year":"2019","unstructured":"DeTomaso, D. et al. Functional interpretation of single cell similarity maps. Nat. Commun. 10, 1\u201311 (2019).","journal-title":"Nat. Commun."},{"key":"57377_CR9","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","volume":"175","author":"L Jerby-Arnon","year":"2018","unstructured":"Jerby-Arnon, L. et al. A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade. Cell 175, 984\u2013997.e24 (2018).","journal-title":"Cell"},{"key":"57377_CR10","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41591-018-0096-5","volume":"24","author":"D Lambrechts","year":"2018","unstructured":"Lambrechts, D. et al. Phenotype molding of stromal cells in the lung tumor microenvironment. Nat. Med. 24, 1277\u20131289 (2018).","journal-title":"Nat. Med."},{"key":"57377_CR11","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","volume":"26","author":"M Liao","year":"2020","unstructured":"Liao, M. et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat. Med. 26, 842\u2013844 (2020).","journal-title":"Nat. Med."},{"key":"57377_CR12","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41593-020-0624-8","volume":"23","author":"N Habib","year":"2020","unstructured":"Habib, N. et al. Disease-associated astrocytes in Alzheimer\u2019s disease and aging. Nat. Neurosci. 23, 701\u2013706 (2020).","journal-title":"Nat. Neurosci."},{"key":"57377_CR13","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"57377_CR14","doi-asserted-by":"publisher","first-page":"e202001004","DOI":"10.26508\/lsa.202001004","volume":"4","author":"A L\u00fctge","year":"2021","unstructured":"L\u00fctge, A. et al. CellMixS: quantifying and visualizing batch effects in single-cell RNA-seq data. Life Sci. Alliance 4, e202001004 (2021).","journal-title":"Life Sci. Alliance"},{"key":"57377_CR15","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/s41587-020-00748-9","volume":"39","author":"W Chen","year":"2020","unstructured":"Chen, W. et al. A multicenter study benchmarking single-cell RNA sequencing technologies using reference samples. Nat. Biotechnol. 39, 1103\u20131114 (2020).","journal-title":"Nat. Biotechnol."},{"key":"57377_CR16","doi-asserted-by":"publisher","unstructured":"Richards, L. M. et al. A comparison of data integration methods for single-cell RNA sequencing of cancer samples. bioRxiv 2021.08.04.453579 https:\/\/doi.org\/10.1101\/2021.08.04.453579 (2021).","DOI":"10.1101\/2021.08.04.453579"},{"key":"57377_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-25960-2","volume":"12","author":"JW Squair","year":"2021","unstructured":"Squair, J. W. et al. Confronting false discoveries in single-cell differential expression. Nat. Commun. 12, 1\u201315 (2021).","journal-title":"Nat. Commun."},{"key":"57377_CR18","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41591-021-01244-6","volume":"27","author":"MX He","year":"2021","unstructured":"He, M. X. et al. Transcriptional mediators of treatment resistance in lethal prostate cancer. Nat. Med. 27, 426\u2013433 (2021).","journal-title":"Nat. Med."},{"key":"57377_CR19","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41591-021-01323-8","volume":"27","author":"A Bassez","year":"2021","unstructured":"Bassez, A. et al. A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer. Nat. Med. 27, 820\u2013832 (2021).","journal-title":"Nat. Med."},{"key":"57377_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41523-023-00508-3","volume":"9","author":"V Debien","year":"2023","unstructured":"Debien, V. et al. Immunotherapy in breast cancer: an overview of current strategies and perspectives. npj Breast Cancer 9, 1\u201310 (2023).","journal-title":"npj Breast Cancer"},{"key":"57377_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2023.103580","volume":"72","author":"G Jerusalem","year":"2023","unstructured":"Jerusalem, G. et al. Neoadjuvant nivolumab + palbociclib + anastrozole for oestrogen receptor-positive\/human epidermal growth factor receptor 2-negative primary breast cancer: results from CheckMate 7A8. Breast 72, 103580 (2023).","journal-title":"Breast"},{"key":"57377_CR22","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1056\/NEJMoa1809615","volume":"379","author":"P Schmid","year":"2018","unstructured":"Schmid, P. et al. Atezolizumab and Nab-Paclitaxel in advanced triple-negative breast cancer. N. Engl. J. Med. 379, 2108\u20132121 (2018).","journal-title":"N. Engl. J. Med."},{"key":"57377_CR23","doi-asserted-by":"publisher","first-page":"781848","DOI":"10.3389\/fcell.2021.781848","volume":"9","author":"J Yao","year":"2021","unstructured":"Yao, J., Li, S. & Wang, X. Identification of breast cancer immune subtypes by analyzing bulk tumor and single cell transcriptomes. Front. Cell Dev. Biol. 9, 781848 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"57377_CR24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.biochi.2023.11.008","volume":"219","author":"Lipid profile in breast cancer.","year":"2024","unstructured":"Lipid profile in breast cancer. From signaling pathways to treatment strategies. Biochimie 219, 118\u2013129 (2024).","journal-title":"Biochimie"},{"key":"57377_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01178-1","volume":"21","author":"D Zipinotti Dos Santos","year":"2023","unstructured":"Zipinotti Dos Santos, D. et al. The impact of lipid metabolism on breast cancer: a review about its role in tumorigenesis and immune escape. Cell Commun. Signal. 21, 161 (2023).","journal-title":"Cell Commun. Signal."},{"key":"57377_CR26","doi-asserted-by":"publisher","first-page":"4934","DOI":"10.3390\/cancers14194934","volume":"14","author":"C Jehanno","year":"2022","unstructured":"Jehanno, C. et al. Hypoxia and ER\u03b1 transcriptional crosstalk is associated with endocrine resistance in breast cancer. Cancers 14, 4934 (2022).","journal-title":"Cancers"},{"key":"57377_CR27","doi-asserted-by":"publisher","first-page":"4968","DOI":"10.1128\/MCB.02244-06","volume":"27","author":"D Wiederschain","year":"2007","unstructured":"Wiederschain, D. et al. Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis. Mol. Cell. Biol. 27, 4968\u20134979 (2007).","journal-title":"Mol. Cell. Biol."},{"key":"57377_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-25769-z","volume":"12","author":"TE Keenan","year":"2021","unstructured":"Keenan, T. E. et al. Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer. Nat. Commun. 12, 1\u201313 (2021).","journal-title":"Nat. Commun."},{"key":"57377_CR29","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu, S. Z. et al. A single-cell and spatially resolved atlas of human breast cancers. Nat. Genet. 53, 1334\u20131347 (2021).","journal-title":"Nat. Genet."},{"key":"57377_CR30","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1158\/1535-7163.MCT-06-0461","volume":"6","author":"AP Taylor","year":"2007","unstructured":"Taylor, A. P. & Goldenberg, D. M. Role of placenta growth factor in malignancy and evidence that an antagonistic PlGF\/Flt-1 peptide inhibits the growth and metastasis of human breast cancer xenografts. Mol. Cancer Ther. 6, 524\u2013531 (2007).","journal-title":"Mol. Cancer Ther."},{"key":"57377_CR31","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/sj.bjc.6605746","volume":"103","author":"AP Taylor","year":"2010","unstructured":"Taylor, A. P., Leon, E. & Goldenberg, D. M. Placental growth factor (PlGF) enhances breast cancer cell motility by mobilising ERK1\/2 phosphorylation and cytoskeletal rearrangement. Br. J. Cancer 103, 82\u201389 (2010).","journal-title":"Br. J. Cancer"},{"key":"57377_CR32","doi-asserted-by":"crossref","unstructured":"Chen C.N. et al. The significance of placenta growth factor in angiogenesis and clinical outcome of human gastric cancer. Cancer Lett. 213, 73\u201382 (2004)..","DOI":"10.1016\/j.canlet.2004.05.020"},{"key":"57377_CR33","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1016\/j.ejca.2005.07.022","volume":"41","author":"C Parr","year":"2005","unstructured":"Parr, C., Watkins, G., Boulton, M., Cai, J. & Jiang, W. G. Placenta growth factor is over-expressed and has prognostic value in human breast cancer. Eur. J. Cancer 41, 2819\u20132827 (2005).","journal-title":"Eur. J. Cancer"},{"key":"57377_CR34","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1136\/gut.2004.050831","volume":"54","author":"S-C Wei","year":"2005","unstructured":"Wei, S.-C. et al. Placenta growth factor expression is correlated with survival of patients with colorectal cancer. Gut 54, 666\u2013672 (2005).","journal-title":"Gut"},{"key":"57377_CR35","first-page":"537","volume":"23","author":"A Escudero-Esparza","year":"2010","unstructured":"Escudero-Esparza, A., Martin, T. A., Douglas-Jones, A., Mansel, R. E. & Jiang, W. G. PGF isoforms, PLGF-1 and PGF-2 and the PGF receptor, neuropilin, in human breast cancer: prognostic significance. Oncol. Rep. 23, 537\u2013544 (2010).","journal-title":"Oncol. Rep."},{"key":"57377_CR36","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1172\/JCI39534","volume":"120","author":"PM Gilbert","year":"2010","unstructured":"Gilbert, P. M. et al. HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype. J. Clin. Investig. 120, 1535\u20131550 (2010).","journal-title":"J. Clin. Investig."},{"key":"57377_CR37","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41577-021-00566-3","volume":"22","author":"AM Gocher","year":"2021","unstructured":"Gocher, A. M., Workman, C. J. & Vignali, D. A. A. Interferon-\u03b3: teammate or opponent in the tumour microenvironment? Nat. Rev. Immunol. 22, 158\u2013172 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"57377_CR38","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","volume":"27","author":"JS Parker","year":"2009","unstructured":"Parker, J. S. et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J. Clin. Oncol. 27, 1160\u20131167 (2009).","journal-title":"J. Clin. Oncol."},{"key":"57377_CR39","doi-asserted-by":"crossref","unstructured":"Oshi, M. et al. Adipogenesis in triple-negative breast cancer is associated with unfavorable tumor immune microenvironment and with worse survival. Sci. Rep. 11, 12541 (2021).","DOI":"10.1038\/s41598-021-91897-7"},{"key":"57377_CR40","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1177\/1947601911432496","volume":"2","author":"V Ossovskaya","year":"2011","unstructured":"Ossovskaya, V. et al. Exploring molecular pathways of triple-negative breast cancer. Genes Cancer 2, 870\u2013879 (2011).","journal-title":"Genes Cancer"},{"key":"57377_CR41","doi-asserted-by":"publisher","first-page":"6834","DOI":"10.3390\/ijms24076834","volume":"24","author":"L Clusan","year":"2023","unstructured":"Clusan, L., Ferri\u00e8re, F., Flouriot, G. & Pakdel, F. A basic review on estrogen receptor signaling pathways in breast cancer. Int. J. Mol. Sci. 24, 6834 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"57377_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-13993-7","volume":"11","author":"N Kim","year":"2020","unstructured":"Kim, N. et al. Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma. Nat. Commun. 11, 1\u201315 (2020).","journal-title":"Nat. Commun."},{"key":"57377_CR43","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.cell.2020.07.017","volume":"182","author":"A Maynard","year":"2020","unstructured":"Maynard, A. et al. Therapy-induced evolution of human lung cancer revealed by single-cell rna sequencing. Cell 182, 1232\u20131251.e22 (2020).","journal-title":"Cell"},{"key":"57377_CR44","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41422-020-0355-0","volume":"30","author":"J Qian","year":"2020","unstructured":"Qian, J. et al. A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling. Cell Res. 30, 745\u2013762 (2020).","journal-title":"Cell Res"},{"key":"57377_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-022-00906-3","volume":"20","author":"F Pouremamali","year":"2022","unstructured":"Pouremamali, F., Pouremamali, A., Dadashpour, M., Soozangar, N. & Jeddi, F. An update of Nrf2 activators and inhibitors in cancer prevention\/promotion. Cell Commun. Signal. 20, 1\u201316 (2022).","journal-title":"Cell Commun. Signal."},{"key":"57377_CR46","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"O Warburg","year":"1927","unstructured":"Warburg, O., Wind, F. & Negelein, E. The metabolism of tumors in the body. J. Gen. Physiol. 8, 519\u2013530 (1927).","journal-title":"J. Gen. Physiol."},{"key":"57377_CR47","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1042\/BST20160094","volume":"44","author":"M Potter","year":"2016","unstructured":"Potter, M., Newport, E. & Morten, K. J. The Warburg effect: 80 years on. Biochem. Soc. Trans. 44, 1499\u20131505 (2016).","journal-title":"Biochem. Soc. Trans."},{"key":"57377_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-021-02997-z","volume":"5","author":"X Li","year":"2022","unstructured":"Li, X. et al. Identifying metabolic reprogramming phenotypes with glycolysis-lipid metabolism discoordination and intercellular communication for lung adenocarcinoma metastasis. Commun. Biol. 5, 1\u201313 (2022).","journal-title":"Commun. Biol."},{"key":"57377_CR49","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1200\/JCO.2010.31.8907","volume":"30","author":"P Sansone","year":"2012","unstructured":"Sansone, P. & Bromberg, J. Targeting the interleukin-6\/Jak\/stat pathway in human malignancies. J. Clin. Oncol. 30, 1005\u20131014 (2012).","journal-title":"J. Clin. Oncol."},{"key":"57377_CR50","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/MPA.0b013e31823cdd10","volume":"41","author":"KM Block","year":"2012","unstructured":"Block, K. M., Hanke, N. T., Maine, E. A. & Baker, A. F. IL-6 stimulates STAT3 and Pim-1 kinase in pancreatic cancer cell lines. Pancreas 41, 773\u2013781 (2012).","journal-title":"Pancreas"},{"key":"57377_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-017-1305-0","volume":"18","author":"L Zappia","year":"2017","unstructured":"Zappia, L., Phipson, B. & Oshlack, A. Splatter: simulation of single-cell RNA sequencing data. Genome Biol. 18, 1\u201315 (2017).","journal-title":"Genome Biol."},{"key":"57377_CR52","doi-asserted-by":"publisher","unstructured":"Johri, S. Vanallenlab\/beanie: v1.0.0. (Zenodo). https:\/\/doi.org\/10.5281\/ZENODO.14617303 (2025).","DOI":"10.5281\/ZENODO.14617303"},{"key":"57377_CR53","doi-asserted-by":"publisher","unstructured":"Johri, S. Vanallenlab\/beanie-Analysis: v1.0.0. (Zenodo). https:\/\/doi.org\/10.5281\/ZENODO.14616985 (2025).","DOI":"10.5281\/ZENODO.14616985"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57377-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57377-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57377-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T04:27:08Z","timestamp":1740803228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57377-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["57377"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-57377-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.10.22.465130","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,1]]},"assertion":[{"value":"8 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.M.V.A. has received research support (to institution) from Novartis and BMS. E.M.V.A. serves as a consultant or on scientific advisory boards of Tango Therapeutics, Genome Medical, Invitae, Enara Bio, Janssen, Manifold Bio, Monte Rosa. E.M.V.A. has equity in Tango Therapeutics, Genome Medical, Syapse, Enara Bio, Manifold Bio, Microsoft, Monte Rosa. E.M.V.A. receives travel reimbursements from Roche\/Genentech. E.M.V.A. has filed institutional patents on chromatin mutations and immunotherapy response, and methods for clinical interpretation, and has intermittent legal consulting on patents for Foaley & Hoag. L.F. has received research support (to institution) from Roche\/Genentech, Abbvie, Bavarian Nordic, Bristol Myers Squibb, Dendreon, Janssen, Merck, and Partner Therapeutics. L.F. has served on the scientific advisory boards of Actym, Allector, Astra Zeneca, Atreca, Bioalta, Bolt, Bristol Myer Squibb, Immunogenesis, Merck, Merck KGA, Nutcracker, RAPT, Scribe, Senti, Soteria, TeneoBio, and Roche\/Genentech. M.X.H. is currently an employee of Genentech\/Roche and has been a consultant to Amplify Medicines, Ikena Oncology, and Janssen. Work in this manuscript was performed when M.X.H. was a PhD student in the Biophysics program at Harvard Medical School. J.C. has been a consultant to Tango Therapeutics. He is also currently an employee of PathAI. N.I.V. serves on advisory boards of Sanofi and Oncocyte. The remaining Authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2090"}}